Bertilimumab

Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11) . Bertilimumab has the potential for allergic disorders research[1].

Product Specifications

CAS Number

[375348-49-5]

Product Name Alternative

CAT 213; iCo-008

UNSPSC

12352203

Target

CCR

Type

Inhibitory Antibodies

Related Pathways

GPCR/G Protein; Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/bertilimumab.html

Purity

97.01

Solubility

10 mM in DMSO

Smiles

[Bertilimumab]

Molecular Weight

(144.18 kDa)

References & Citations

[1]Sarah Main, et al. A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacy. J Pharmacol Exp Ther. 2006 Dec;319 (3) :1395-404.